ArticleBlood advances2025
Asciminib for relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Mathilde Chanut et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleBlood advances2025
Mathilde Chanut et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.